Viewing StudyNCT01953926

Bugs

eRecord

Ignite Creation Date: 2024-05-06 @ 2:01 AM

Last Modification Date: 2024-10-26 @ 11:13 AM

Study NCT ID: NCT01953926

Status: TERMINATED

Last Update Posted: 2024-03-12

First Post: 2013-09-26

Brief Title: Basket Study of Neratinib in Participants With Solid Tumors Harboring Somatic HER2 or EGFR Exon 18 Mutations

Sponsor: Puma Biotechnology Inc

Organization: Puma Biotechnology Inc

Overview Dates Organization Conditions Design Enrollment Locations Outcomes

Conditions:

Name

Solid Tumors Harboring Somatic HER2 or EGFR Exon 18 Mutations

Keywords:

Name	View

Non-Small Cell Lung Cancer NSCLC	View
Neratinib	View
Nerlynx	View
Breast	View
Solid Tumors	View
Cancer	View
HER2 mutations	View
EGFR mutations	View
Fulvestrant	View
Trastuzumab	View
Cervical	View
Salivary	View
ERBB2	View
Exon 18	View
Metastatic	View
HR Positive	View
Lung	View